by Alex Kadhim
An international multicenter retrospective study has evaluated the safety and efficacy of anti-CD19 CAR-T cell treatment for patients with Richter transformation (RT), a condition known for a poor...
by Alex Kadhim
A recent study, published in Nature Microbiology, has found that changes in bile acid (BA) composition and signaling might contribute to graft-versus-host disease (GVHD) pathogenesis, highlighting...
by Blood Advances
Evidence suggests posoleucel is safe and effective prophylaxis against clinically significant infections (CSIs) in allogeneic hematopoietic cell transplantation (allo-HCT) recipients, whose lack...
by Alex Kadhim
Graft-versus-host disease (GvHD) remains a challenge in the realm of allogeneic hematopoietic cell transplantation (allo-HCT), with the choice of prophylaxis strategy playing a critical role in...
by Blood Advances
Based on promising results with third-party fecal microbiota transplantation (FMT), scientists are urged to explore microbiome-targeted interventions as an early treatment for acute...
by Cell Reports Medicine
A novel co-targeting design promises to heighten the effects of chimeric antigen receptor (CAR) T-cell activity in certain B-cell lymphoma patients, a population that can benefit from CAR...